Sermorelin vs ipamorelin: how they differ and which is prescribed
Sermorelin and ipamorelin both raise growth hormone, through different receptors. Compare how they work, evidence, FDA status, side effects and access.
The short answer
Sermorelin copies growth hormone releasing hormone, while ipamorelin mimics ghrelin, and both prompt the pituitary to release growth hormone. Sermorelin was once an FDA-approved drug. Ipamorelin has never been approved for any use, and FDA has been reviewing whether pharmacies may compound it.
- Sermorelin Injection is $219/month (billed $219 every 30 days), charged only after a clinician approves it.
- Answer a few health questions online. A licensed clinician reviews them. If approved, it ships to your door.
- Adults 18 or older. A licensed clinician reviews your health history and decides whether treatment is appropriate for you. Availability depends on the state you live in.

Sermorelin and ipamorelin are often sold together as growth hormone peptides. They reach the same goal through different receptors and have very different regulatory histories. This guide compares how they work, what the evidence shows, side effects, and which one a licensed clinician can prescribe.
- Sermorelin acts on the GHRH receptor. Ipamorelin acts on the ghrelin (growth hormone secretagogue) receptor.
- Sermorelin was approved as Geref for children with growth hormone deficiency. Ipamorelin was never approved.
- Human evidence for adult wellness goals is limited for both.
- Ipamorelin is widely sold as a research peptide with no pharmacy oversight.
Sermorelin vs ipamorelin at a glance
| Sermorelin | Ipamorelin | |
|---|---|---|
| What it mimics | Growth hormone releasing hormone (GHRH) | Ghrelin |
| Receptor | GHRH receptor on the pituitary | Growth hormone secretagogue receptor (GHSR) |
| FDA history | Approved as Geref for children, later withdrawn by its maker | Never approved for any use |
| Compounding status | Prescribed from compounding pharmacies | Under FDA review as a compounding ingredient |
| Human trials | Pediatric approval trials, small adult studies | Phase 2 trials for bowel recovery after surgery |
| Available at Vitals Vault | Yes, after a clinician review | No |
What the evidence shows
Sermorelin
Approved for children with growth hormone deficiency based on growth outcomes. Adult studies are small and show rises in growth hormone and IGF-1 more consistently than changes people feel.
Ipamorelin
Developed as a selective growth hormone releaser. Its largest human trials tested bowel recovery after surgery, not aging, muscle or sleep, and did not lead to approval.
Using them together
Blends are popular because the two pathways may add up. There are no published trials of the combination in adults.
Key differences that matter
Sermorelin
- Works through the body's normal GHRH signal
- Has a past FDA approval and an established compounding route
- Daily injection, usually at bedtime
Ipamorelin
- Works through the ghrelin pathway
- Never approved, and its compounding status is unsettled
- Mostly sold as a research peptide
Side effects and warnings
| Sermorelin | Ipamorelin | |
|---|---|---|
| Common | Injection-site reactions, flushing, headache | Injection-site reactions, headache, nausea |
| Appetite | Little effect | May increase hunger, as ghrelin does |
| Shared concerns | Higher blood sugar, fluid retention, joint pain if IGF-1 rises too high | Same |
Which one a clinician may prescribe
If you want a prescription option
Sermorelin is the one a licensed clinician can prescribe through a compounding pharmacy. Your clinician reviews your history and may check IGF-1 first.
If you are considering ipamorelin
Ask about its current legal status and sourcing. Avoid research-use products.
If you have diagnosed growth hormone deficiency
Adults with confirmed deficiency are treated with growth hormone itself, under an endocrinologist.
Frequently Asked Questions
Is sermorelin or ipamorelin better?
There are no head-to-head trials. Sermorelin has a past FDA approval and is prescribed through compounding pharmacies. Ipamorelin was never approved.
Can you take sermorelin and ipamorelin together?
They are often blended, but there are no published adult trials of the combination. Talk to a clinician before combining peptides.
Is ipamorelin legal?
Ipamorelin has never been FDA-approved, and FDA has been reviewing whether pharmacies may compound it. Products sold for research use are not meant for people.
Does ipamorelin increase hunger?
It acts on the ghrelin receptor, and ghrelin drives appetite. Some people report more hunger.
Which has fewer side effects?
Both commonly cause injection-site reactions and headache. Long-term safety data are limited for both.